GPR56:GPCR

Yuelong Yan1, Li Zhuang1, Boyi Gan2

  • 1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Cell metabolism
|November 6, 2024
PubMed
概括

GPR56是一种G蛋白结合受体,抑制细胞死亡通路ferroptosis. 这一发现为减轻与铁死相关的肝损伤提供了一个新的治疗点.